Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals

Lauren E. Cain, Ellen C. Caniglia, Andrew Phillips, Ashley Olson, Roberto Muga, Santiago Pérez-Hoyos, Sophie Abgrall, Dominique Costagliola, Rafael Rubio, Inma Jarrín, Heiner Bucher, Jan Fehr, Ard van Sighem, Peter Reiss, François Dabis, Marie Anne Vandenhende, Roger Logan, James Robins, Jonathan A.C. Sterne, Amy JusticeJanet Tate, Giota Touloumi, Vasilis Paparizos, Anna Esteve, Jordi Casabona, Rémonie Seng, Laurence Meyer, Sophie Jose, Caroline Sabin, Miguel A. Hernán, HIV-CAUSAL Collaboration

Research output: Contribution to journalArticle (Academic Journal)peer-review

3 Citations (Scopus)
328 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Mathematics

Immunology and Microbiology